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UNIT 11.11Site-Specific Fluorescent Labeling of
Large RNAs with Pyrene
RNAmolecules that adopt specific folded conformations participate inmany biochemical
processes. A fundamental description of RNA folding pathways will allow for a more
complete understanding of the roles that RNA plays in biochemistry. UNIT 11.8 provides an
overview of fluorescence studies of RNA folding, and UNIT 11.10 specifically describes the
application of fluorescence resonance energy transfer (FRET) methods. This unit focuses
on the preparation of large RNAs—those generally >80 nucleotides (nt) in length—with
covalently attached pyrene as a fluorescence probe. This approach uses just one chro-
mophore per RNA molecule and is not based on FRET. Typically, the emission intensity
of the pyrene chromophore is monitored as a function of solution conditions (e.g., Mg2+
concentration), and these emission intensity measurements are used to infer the popu-
lations of various RNA conformational states (Silverman and Cech, 1999b). Although
this approach does not provide high-resolution information such as that obtained from
synchrotron hydroxyl radical footprinting (UNIT 11.6), fluorescence emission intensity data
can provide a simple yet meaningful overview of an RNA folding pathway. Furthermore,
such data are generally easy to obtain with common and relatively inexpensive spectrom-
eters, as long as the fluorescently labeled RNAs can be prepared. The specific task of
preparing pyrene-labeled RNA is the focus of this contribution.
This unit describes protocols for synthesizing large RNAs that are derivatizedwith pyrene
attached via a short tether at a specific internal nucleotide position. Basic Protocol 1 de-
scribes the procedure for pyrene derivatization of the 2′-amino group of a short synthetic
RNA oligonucleotide (<40 nt in length). This is required as the first step in prepara-
tion of large pyrene-labeled RNAs. The second step is to join the pyrene-derivatized
oligonucleotide with a second, unlabeled RNA fragment to form the desired full-length
RNA. Basic Protocol 2 describes a ligation procedure for this purpose. Basic Protocol
3 describes an annealing procedure to be used when the pyrene-labeled oligonucleotide
does not need to be covalently joined to the remainder of the large RNA for it to adopt
proper tertiary structure. Each of these protocols has been developed using the pyr3 chro-
mophore shown in Figure 11.11.1 attached at the 2′-position of specific RNA nucleotides
(Silverman and Cech, 1999b). This and other pyrene derivatives are useful in terms of
fluorescence response when placed at various nucleotides within the P4-P6 domain of the
Tetrahymena group I intron RNA (M.K. Smalley and S.K. Silverman, unpub. observ.).
The P4-P6 RNA (Cate et al., 1996) has often been used as a test system for studies of
RNA folding by fluorescence (Silverman and Cech, 1999b, 2001; Silverman et al., 2000;
Young and Silverman, 2002), among other experiments. Pyrene labeling has not yet been
studied systematically in large RNAs other than P4-P6. The protocols described here will
assist such experiments.
NOTE: For all protocols in this unit, samples should be mixed in the order indicated.
After each addition of reagents, the sample tube should bemixed gently (unless otherwise
indicated) and microcentrifuged briefly to collect all of the sample at the bottom of the
tube. See the note at the beginning of UNIT 11.10 regarding general precautions necessary
for working with RNA. Any pyrene-containing samples should be kept away from light
as much as possible to avoid photodegradation of the chromophore.
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Figure 11.11.1 Reaction of the sulfotetrafluorophenyl (STP) ester pyr3-STP with a 2′-amino group, leading to pyr3-
derivatized RNA, which is shown as a pyrene-labeled uridine nucleotide.
STRATEGIC PLANNING
Preparing Pyrene-Labeled RNA Oligonucleotides: Direct Solid-Phase Synthesis
Versus Postsynthetic Labeling
The P4-P6 RNA is 160 nt in length, which is too large to be prepared directly by solid-
phase synthesis. Therefore, to incorporate a pyrene chromophore at a specific internal
position, at least two RNA fragments must be assembled. As shown in Figure 11.11.2A,
pyrene is initially incorporated into a smaller portion of the RNA either by solid-phase
synthesis using a phosphoramidite monomer (Silverman et al., 2000) or by derivatizing
a short RNA oligonucleotide with a suitable reagent such as the sulfotetrafluorophenyl
(STP) ester pyr3-STP (Fig. 11.11.1). The latter derivatization procedure is described in
Basic Protocol 1.
At present, the only pyrene-labeled nucleotide that is available via a commercial solid-
phase RNA synthesis service is pyr3-labeled uridine (Fig. 11.11.1), which is offered by
Dharmacon (http://www.dharmacon.com; 2′-P-U nucleotide). Dharmacon also provides
RNA oligonucleotides containing unlabeled 2′-amino-2′-deoxyuridine or 2′-amino-2′-
deoxycytidine; currently, the adenosine and guanosine derivatives are not commercially
available. Either of these amino-derivatized nucleotides may be postsynthetically deriva-
tized with pyr3-STP according to Figure 11.11.1 to form pyrene-labeled RNA. It is
anticipated that as the pyrene fluorescence method is more widely adopted (e.g., Blount
and Tor, 2003), the direct solid-phase synthesis of pyrene-labeled RNA oligonucleotides
will become more readily available through commercial sources. In addition, Chem-
Genes (http://www.chemgenes.com) offers the pyrimidine 2′-amino-2′-deoxynucleotide
phosphoramidite monomers for solid-phase RNA synthesis by individual investigators.
Assembling a Large Pyrene-Labeled RNA: Ligation Versus Annealing
Once a pyrene-labeled RNA oligonucleotide is in hand, it can be used in the assembly of a
large RNA. For P4-P6, two assembly approaches have been reported: ligation (Silverman
and Cech, 1999b) and annealing (Golden et al., 1996). In the ligation approach, the short
pyrene-labeled RNA oligo is covalently joined using T4 DNA ligase to a second RNA
fragment that encompasses the remaining nucleotides of P4-P6 (Fig. 11.11.2B; Basic
Protocol 2). Alternatively, in the annealing approach, the ligation reaction is omitted
because the short oligonucleotide bearing the pyrene label can hybridize noncovalently
with the remainder of the RNA, as shown schematically in Figure 11.11.2C. After the
derivatization, the annealing step of Basic Protocol 3 is performed, using a modest excess
of the unlabeled RNA to ensure that all of the labeled RNA becomes part of a full-length
RNA complex.
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Figure 11.11.2 Synthetic approaches for large pyrene-labeled RNAs. (A) Preparing a short
pyrene-labeled RNA oligonucleotide either by solid-phase synthesis or by derivatizing a 2′-amino-
RNA with pyr3-STP (Basic Protocol 1). (B) Covalently ligating the short pyrene-labeled RNA to
form a full-length labeled RNA (Basic Protocol 2). (C) Noncovalently annealing the short pyrene-
labeled RNA to the remainder of the large RNA to form full-length RNA without ligation (Basic
Protocol 3).
The ligation procedure of Basic Protocol 2 is required when the RNA backbone must be
intact. In contrast, if a nick in the backbone is tolerated—that is, if the RNA fragment
bearing the pyrene chromophore does not have to be covalently joined to the remainder
of the RNA for proper structure—then the procedure of Basic Protocol 2 is unnecessary,
and Basic Protocol 3 is performed instead. The choice of assembly strategies will be
determined by the specific requirements of the large RNA being studied, as discussed in
the Commentary (see Critical Parameters).
BASIC
PROTOCOL 1
DERIVATIZATION OF A 2′-AMINO RNA OLIGONUCLEOTIDE WITH
PYRENE
Derivatizing the RNA oligonucleotide with pyrene requires that the RNA have an appro-
priately reactive 2′-amino group and that a suitably activated pyrene reagent be available.
This protocol describes the use of pyr3-STP to derivatize a 2′-amino group, forming a
pyr3-labeled RNA oligonucleotide, as shown in Figure 11.11.1. If the pyrene-labeled
RNA is obtained directly from solid-phase synthesis, then most of Basic Protocol 1 is not
necessary, and the preparation can be continued with Basic Protocol 2 or Basic Protocol 3
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as appropriate. In all cases, however, the oligonucleotide should be purified by denaturing
polyacrylamide gel electrophoresis as described below.
Materials
RNA oligonucleotide with a 2′-amino group
500 mM sodium phosphate buffer, pH 8.0 (APPENDIX 2A)
10 mM EDTA, pH 8.0 (APPENDIX 2A)
50 mM pyrene 4-sulfotetrafluorophenyl ester (pyr3-STP; Molecular Probes or Gee
et al., 1999) in N,N-dimethylformamide (DMF)
3 M NaCl (prepared directly or diluted from 5 M NaCl; see APPENDIX 2A)
Absolute ethanol (e.g., Fisher)
80% formamide gel loading buffer with dye (see recipe)
TEN buffer (see recipe)
1.7-mL RNase-free microcentrifuge tubes (e.g., Eppendorf or Fisher)
Speedvac evaporator (Savant)
Glass rod
50-mL plastic tube (e.g., Fisher)
Platform rocker (Clay-Adams Nutator or equivalent)
0.45-µm syringe filter (e.g., Fisher)
40-mL polypropylene tube (e.g., Oak Ridge tube from Fisher)
Tabletop centrifuge (e.g., IEC HN-SII), chilled to 4◦C
Refrigerated centrifuge (e.g., Beckman J2-HS with Beckman JS-13.1 rotor)
Additional reagents and equipment for denaturing polyacrylamide gel
electrophoresis (PAGE; APPENDIX 3B)
Derivatize oligonucleotide
1. Dissolve the 2′-amino-RNA in water to make a 500 µM solution.
This RNA may be obtained either from a commercial supplier or by solid-phase synthesis
in an individual laboratory (see Strategic Planning).
2. Combine the following in a 1.7-mL microcentrifuge tube (total 125 µL):
20 µL 500 µM RNA from step 1 (10 nmol)
50 µL 500 mM sodium phosphate buffer, pH 8.0
5 µL 10 mM EDTA, pH 8.0
50 µL H2O.
If the RNA stock solution is at a concentration other than 500 µM, adjust the amount
of water accordingly.
3. Add 125 µL of 50 mM pyr3-STP in DMF, and incubate the resulting clear solution
at room temperature for 24 hr.
The final concentrations during incubation are 40 µM RNA, 100 mM sodium phosphate,
0.2 mM EDTA, 25 mM pyr3-STP, and 50% (v/v) DMF.
4. Remove 125 µL of the 250-µL sample to a second 1.7-mL microcentrifuge tube. To
each tube add 175 µL water, to a total volume of 300 µL.
5. To each tube add 30 µL of 3 M NaCl and 900 µL absolute ethanol, and vortex the
sample for 10 sec. Freeze the samples on dry ice for at least 20 min or in a −80◦C
freezer for at least 1 hr.
6. Microcentrifuge the samples at least 30 min at maximum speed (∼16,000 × g), 4◦C,
to precipitate the crude pyrene-labeled RNA.
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7. Remove the supernatants with a micropipettor and dry the pelleted samples in a
Speedvac evaporator for 5 min. Redissolve each pellet in 50 µL water and combine
the two samples.
Purify derivatized RNA
8. To the 100-µL sample, add 250 µl of 80% formamide gel loading buffer with dye.
Purify the sample by denaturing PAGE (APPENDIX 3B) on a 20% gel that is 3 mm thick
on 26× 20–cmglass plates. Use one lane of a three-lane gel for a single derivatization
sample. Set the power supply at 30 W and electrophorese the sample for 4 to 5 hr.
9. Excise the band that corresponds to the derivatized RNA (see gel purification method
in UNIT 11.10).
The desired band migrates slightly more slowly than the band corresponding to under-
ivatized RNA (see Commentary).
10. Manually crush the excised gel band with a glass rod in a 50-mL plastic tube.
11. To extract the RNA, add 6 to 7 mL TEN buffer and place the sample tube on a
platform rocker at 4◦C for 6 to 12 hr. Centrifuge the sample at least 10 min at
200 × g (1000 rpm in IEC HN-SII), 4◦C, and filter through a 0.45-µm syringe filter
into a 40-mL polypropylene tube.
12. Extract again as in step 11 and combine the two extracts for a total eluted volume of
10 mL.
The extraction will require a total of ∼12 to 13 mL of TEN buffer, of which 2 to 3 ml
remains absorbed into the polyacrylamide pellet and is unrecoverable.
13. Add 27mL cold absolute ethanol to the combined TEN elutions and place the sample
at −20◦C for at least 6 hr.
14. Precipitate the RNA by centrifuging 30 min at ∼10,000 × g (8000 rpm in Beckman
JS-13.1 rotor), 4◦C.
15. Wash the pellet by adding 1 ml cold 75% ethanol, centrifuging 10 min as in step
14, and removing the ethanol by pipetting. Dry under vacuum for 10 min. Dissolve
sample in 300 µL water and quantitate by UV absorbance (A260).
A typical isolated yield of derivatized RNA is 3 to 5 nmol starting from 10 nmol at step 1.
BASIC
PROTOCOL 2
ASSEMBLY OF THE LARGE RNA BY LIGATION
When the full-length RNA must be assembled using covalent ligation (Fig. 11.11.2B),
this protocol is used. Ligation is performed using T4 DNA ligase and a complementary
DNA splint that extends for at least ten nucleotides on either side of the ligation junction
(Moore and Sharp, 1992; Moore and Query, 1998; Silverman and Cech, 1999a). Because
yields from such splint ligation reactions can vary widely, optimization is necessary (see
Commentary).
Materials
PAGE-purified pyrene-derivatized RNA oligonucleotide (see Basic Protocol 1)
DNA splint oligonucleotide (e.g., Integrated DNA Technologies or other
commercial supplier)
Polynucleotide that constitutes the remaining portion of the large RNA (e.g.,
transcribed from a plasmid DNA template, as described in Silverman and Cech,
1999a)
10× annealing buffer (see recipe)
10× ligation buffer (see recipe)
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T4 DNA ligase (e.g., USB; see Commentary)
80% formamide gel loading buffer with dye (see recipe)
1.7-mL RNase-free microcentrifuge tubes (e.g., Eppendorf or Fisher)
Dry heating block
Additional reagents and equipment for denaturing polyacrylamide gel
electrophoresis (PAGE; APPENDIX 3B)
1. Place 2.0 nmol of pyrene-derivatized RNA oligonucleotide into a 1.7-mL microcen-
trifuge tube.
2. Add 3.0 nmol (1.5 eq) of the DNA splint and 3.2 nmol (1.6 eq) of the polynucleotide
that constitutes the remaining portion of the large RNA. Evaporate the sample to
dryness on a Speedvac evaporator and redissolve in 90 µl water.
Alternatively, if the sample volume after mixing all components is less than 90 µL, omit
the evaporation step and add sufficient water to raise the sample volume to 90 µL. Lower
yields of RNA ligation are observed if an excess of the DNA splint and RNA polynucleotide
is not used (see Commentary).
3. Add 10 µl of 10× annealing buffer. Anneal the sample by heating in a dry heating
block to 95◦C for 3 min and cooling on ice for 5 min.
4. Equilibrate the sample by heating in a water bath at 37◦C for 2 min.
5. Add 12.5 µl of 10× ligation buffer followed by 12.5 µL of T4 DNA ligase. Incubate
the sample in a water bath at 37◦C for 4 hr.
6. Add 200 µl of 80% formamide gel loading buffer with dye. Purify the sample by
denaturing PAGE (APPENDIX 3B) on a 12% gel that is 1.5 mm thick on 26 × 20–cm
glass plates. Use one lane of a three-lane gel for a single ligation sample. Set the
power at 30 W and electrophorese the sample for 7 to 8 hr.
The separation between unligated and ligated RNA must be optimized depending on the
exact sizes of the RNAs (see Commentary).
7. Excise the band that corresponds to the ligated RNA (see gel purification method in
UNIT 11.10) and extract and precipitate the RNA (see Basic Protocol 1, steps 9 to 15).
A typical isolated yield of ligated RNA is 0.5 to 0.8 nmol starting from 2.0 nmol at step 1.
8. Proceed to the fluorescence experiments using the RNA sample.
BASIC
PROTOCOL 3
ASSEMBLY OF THE LARGE RNA BY ANNEALING
When the full-length RNA can be assembled by noncovalently hybridizing the pyrene-
labeled fragment to the remainder of the RNA (Fig. 11.11.2C), this protocol is used. As
for most annealing procedures, this protocol should not be followed until fluorescence
experiments are ready to be performed on the annealed sample (see UNIT 11.8). Typically,
an excess of the unlabeled RNA relative to pyrene-labeled RNA is used. This ensures
that all of the pyrene label is found within a full-length RNA assembly.
Materials
PAGE-purified pyrene-derivatized RNA oligonucleotide (see Basic Protocol 1)
Polynucleotide that constitutes the remaining portion of the large RNA (e.g.,
transcribed from a plasmid DNA template, as described in Silverman and Cech,
1999a)
10× TB buffer (equivalent to 10× TBE but omitting EDTA; see APPENDIX 2A)
1.7-mL RNase-free microcentrifuge tubes (e.g., Eppendorf or Fisher)
Dry heating block
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1. Place 0.2 nmol of the pyrene-derivatized RNA oligonucleotide from Basic Protocol
1 into a 1.7-mL microcentrifuge tube.
2. Add 0.8 nmol (4 eq) of the polynucleotide that constitutes the remaining portion of
the large RNA.
3. Add sufficient water to obtain a total volume of 603 µL.
4. Add 67 µL of 10× TB buffer, providing a total sample volume of 670 µL in 1× TB
buffer.
5. Anneal the sample by heating to 60◦C for 10 min in a dry heating block and cooling
at room temperature on the benchtop for 10 min.
This volume of sample is sufficient to provide at least 650 µL for transfer to a standard
fluorescence cuvette. The heating temperature during annealing is kept down to 60◦C to
avoid nonspecific RNA degradation.
EDTA is omitted from the sample during this process, because fluorescence experiments
often involve addition of small amounts of Mg2+ as part of a detailed titration series
(Silverman and Cech, 1999b). The buffer used may be varied (see Commentary).
6. Proceed to the fluorescence experiments using the RNA sample.
REAGENTS AND SOLUTIONS
Use deionized RNase-free water in all recipes and protocol steps. Do not use DEPC-treated water
(see UNIT 11.10 for precautions to avoid RNase contamination). For common stock solutions, see
APPENDIX 2A. For suppliers, see SUPPLIERS APPENDIX.
10× annealing buffer
50 µL 1 M Tris·Cl, pH 7.5 (APPENDIX 2A; 50 mM final)
2 µl 0.5 M EDTA, pH 8.0 (APPENDIX 2A; 1 mM final)
Dilute to 1 mL with H2O
Store up to 1 year at room temperature
Formamide gel loading buffer with dye (80% formamide)
Place 25 mg each of xylene cyanol and bromphenol blue into an autoclaved
125-mL glass bottle. Add 80 mL formamide (e.g., Fisher), 10 mL 10× TBE
buffer, and 10 mL 0.5 M EDTA (see APPENDIX 2A for the latter two reagents). Swirl
the components to mix completely. Do not autoclave, which will decompose the
formamide. Store up to 1 year at 4◦C.
Ligation buffer, 10×
500 µL 1 M Tris·Cl, pH 8.0 (APPENDIX 2A; 500 mM final)
100 µL 1 M MgCl2 (100 mM final)
300 µL 250 mM dithiothreitol (DTT; 75 mM final)
100 µL 100 mM ATP (10 mM final)
Store up to 1 year at −20◦C (avoid repeated freeze-thaw cycles, which may
decompose the ATP)
TEN (Tris/EDTA/NaCl) buffer
4 mL 1 M Tris·Cl, pH 8.0 (APPENDIX 2A; 10 mM final)
800 µL 0.5 M EDTA, pH 8.0 (APPENDIX 2A; 1 mM final)
40 mL 3 M NaCl (or 24 mL 5 M NaCl; APPENDIX 2A; 300 mM final)
Dilute to 400 mL with H2O
Sterilize by autoclaving
Store up to 1 year at room temperature
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COMMENTARY
Background Information
Fluorescence methods are widely used
throughout biochemistry to monitor confor-
mational changes (Whitaker, 2000; Mollova,
2002). In particular, fluorescence approaches
have been employed in many cases with RNA.
The 2-aminopurine nucleobase is often used
(Millar, 1996), but the fluorescence changes
upon RNA folding are frequently small; the
responses are largest when the nucleobase
changes its stacking during the RNA fold-
ing event. Several reports have demonstrated
that pyrene is a useful probe of RNA tertiary
structure. In principle, a pyrene chromophore
may be incorporated at either the 5′-terminus
(Bevilacqua et al., 1992; Kierzek et al., 1993)
or 3′-terminus (seeChapter 4 for terminalmod-
ifications of oligonucleotides). Alternatively,
pyrene may be incorporated at an internal nu-
cleotide position (Silverman and Cech, 1999b,
2001; Silverman et al., 2000; Young and Sil-
verman, 2002; Blount and Tor, 2003). Al-
though site-specific labeling at a terminus is
generally possible for anyRNAsequence, each
RNA necessarily has many more internal po-
sitions than termini. These internal positions
offer greater opportunity formonitoring differ-
ent phases of RNA folding depending on the
location of the chromophore. Circular permu-
tation (Pan and Uhlenbeck, 1993; Pan, 2000)
can convert an internal RNA position into a
terminus, thereby overcoming this limitation.
However, some sites of interest for derivatiza-
tion will require maintaining the local back-
bone connectivity for proper RNA structure,
and thus these positions are unsuitable for the
circular permutation approach. This necessi-
tates an assembly strategy in which the chro-
mophore is incorporated internally into the
large RNA.
The assembly strategies shown in Figure
11.11.2 are in principle applicable to any large
RNA. However, several practical issues must
be addressed. First, solid-phaseRNAsynthesis
has a limit (∼80 nt) that is much smaller than
many large RNAs, which may have up to sev-
eral hundred nucleotides. Therefore, the major
challenge in preparing large site-specifically
modified RNAs is the assembly of multiple
RNA fragments, one or more of which have
nonstandard nucleotides. This assembly re-
quires either the ligation or annealing strat-
egy of Figure 11.11.2B or C, depending on
whether or not the RNA tolerates a break in
the backbone at the chosen location (see Crit-
ical Parameters). Second, if the site of chro-
mophore incorporation is not near one of the
termini, and therefore the short pyrene-labeled
RNA oligonucleotide lies near the middle of
the large RNA,multiple ligation reactionsmay
be necessary to prepare the full-length modi-
fiedRNA.Although numerous ligations can be
performed sequentially, the final yields nec-
essarily suffer (Silverman and Cech, 1999a).
Fluorescence experiments require sufficiently
large amounts of pyrene-labeled RNA (typi-
cally nanomoles) that multiple ligations are
to be avoided whenever possible. The fluo-
rescence experiments reported to date that use
RNA ligation require just one ligation reaction
to provide properly folded RNA.
Once a reasonable synthesis strategy has
beendesigned and the pyrene-labeledRNAhas
been prepared, either equilibrium titration or
stopped-flow experiments may be performed
(Bevilacqua et al., 1992; Kierzek et al., 1993;
Silverman and Cech, 1999b, 2001; Silverman
et al., 2000; Young and Silverman, 2002). It
is also possible to monitor other fluorescence
characteristics of the pyrene, such as its fluo-
rescence lifetime and anisotropy (Preuss et al.,
1997; Walter et al., 1998). The protocols de-
scribed in this unit should facilitate applying
these methods to an increasing array of inter-
esting large RNA structures.
Critical Parameters
RNA derivatization with pyrene
The derivatization method described in
Basic Protocol 1 has been optimized for the
specific reaction shown in Figure 11.11.1. The
reactions used a 15-mer 2′-amino-modified
oligonucleotide corresponding to the first 15
nt of P4-P6, in which the 2′-amino group
was on U107, the sixth nucleotide from
the 5′-end. In the initial report (Silverman
and Cech, 1999b), an N-hydroxysuccinimide
(NHS) ester was used as the activated pyrene
reagent; subsequently, the more water-soluble
4-sulfotetrafluorophenyl (STP) ester (Gee
et al., 1999) was found to provide faster la-
beling with higher yield (M.K. Smalley and
S.K. Silverman, unpub. observ.). For individ-
ual small-scale reactions, purchasing the pyr3-
STP reagent is likely the most expedient op-
tion. For larger-scale reactions or for multi-
ple derivatizations, preparing the reagent ac-
cording to the published procedure (Gee et al.,
1999) would be worthwhile.
The authors have also found that a 24-
mer 2′-amino-modified oligonucleotide cor-
responding to the last 24 nt of P4-P6
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(Golden et al., 1996) may be derivatized suc-
cessfully under the same conditions when the
2′-amino-nucleotide is located at various sites
within the 24-mer. For unrelated 2′-amino-
RNAs that would be required for other large
RNAs, the derivatization efficiency should
be checked by analytical-scale assays before
committing a large amount of material to the
procedure. The variables to adjust include the
buffer identity and pH (sodium phosphate,
pH 7 to 8, or bicine, pH 8 to 9), reaction
temperature (16◦ to 60◦C), and incubation
time (1 to 24 hr). To facilitate the quantifi-
cation of these assays, a small portion of the
oligonucleotide should be 5′-32P-radiolabeled
(e.g., UNITS 6.1 & 10.4), which permits the assay
to be monitored using analytical-scale PAGE
and a PhosphorImager (Silverman and Cech,
1999b).
An important concern in the derivatization
protocol is the extent of nonspecific labeling
of various nucleophilic sites on the oligonu-
cleotide other than the 2′-amino group. The
extent of nonspecific labeling may be assessed
by performing the derivatization reaction on an
unmodified oligonucleotide that has the same
RNA sequence but lacks the 2′-amino group.
For the unmodified 15-mer oligonucleotide
corresponding to the first 15 nt of P4-P6, non-
specific labeling occurs to the extent of 5% to
8% under the conditions of Basic Protocol 1.
This is compared with specific labeling to the
extent of ∼75% for an RNA oligonucleotide
of the same sequence with a single 2′-amino
group.
To avoid decomposition, small aliquots of
pyr3-STP stock solution (<100 µL) should
be stored in a −80◦C freezer and kept on ice
when not in immediate use. If the derivatiza-
tion reaction is unsuccessful, then the purity of
the pyr3-STP should be checked by thin-layer
chromatography (APPENDIX 3D), and the sam-
ple should be discarded or repurified by silica
gel column chromatography (APPENDIX 3E) as
necessary.
RNA ligation
The yields of T4 DNA ligase–mediated
splint ligations vary widely depending on the
exact sequence and structural context of the
ligation site. Therefore, for any new RNA
ligation, the efficiency must be optimized on a
small scale using 32P-radiolabeled samples as
required. The ratio of the two RNA fragments
and the DNA splint are generally chosen such
that one RNA fragment is the limiting reagent
and the other two nucleic acids are in modest
excess (a 1:1:1 ratio of the three components
usually gives poor results). The amounts
and ratios reported in Basic Protocol 2 were
chosen based on empirical data, with the con-
sideration that the pyrene-derivatized RNA
oligonucleotide is typically the most precious
of the three fragments and is therefore the
limiting reagent.
Despite significant optimization attempts,
it is sometimes the case that a particular splint
ligation cannot be achieved in high yield (e.g.,
Sontheimer et al., 1999; Strobel and Ortoleva-
Donnelly, 1999). If so, the most expedient
strategy may be to redesign the experiment to
avoid that particular ligation site, becausemov-
ing the ligation site by even just one nucleotide
can have an unpredictable and often substantial
effect on the ligation efficiency. Ongoing ef-
forts with deoxyribozymes (Flynn-Charlebois
et al., 2003) may alleviate some of the difficul-
ties associated with T4 DNA ligase–mediated
splint ligations.
Several commercial suppliers provide T4
DNA ligase. However, the enzyme from some
sources may be ineffective owing to insuffi-
cient degree of purification or insufficient con-
centration. Because the availability of T4DNA
ligase from various manufacturers changes
with time, this must be tested empirically. The
authors generally useHis6-taggedT4DNA lig-
ase prepared in-house from a plasmid clone
provided by Scott Strobel (Yale University).
The amount of T4 DNA ligase required for a
specific scale of ligation reaction is optimized
for each batch of enzyme.
After the ligation reaction has been per-
formed, the sample is purified by denaturing
PAGE (APPENDIX 3B). The percentage of acryl-
amide and the running time must be optimized
for each ligation reaction, depending on the
sizes of the unligated and ligated RNA. Gener-
ally, because the pyrene-derivatized fragment
is a relatively short oligonucleotide (<40 nt)
and the remainder of the RNA is often very
large (>100 nt), the physical separation on the
gel between unligated and ligated RNA may
be small. For ligation of the pyrene-derivatized
15-mer oligonucleotide to the 145-mer corre-
sponding to the remainder of P4-P6 (Silver-
man and Cech, 1999a,b), the observed separa-
tion requires a higher-than-usual percentage of
acrylamide (12%) for that length of RNA, and
consequently a longer running time (∼7 to 8 hr
for a 1.5-mm-thick gel). For a lower percentage
of acrylamide (e.g., 6%), whichwould bemore
typical for such a large RNA, the separation
between unligated and ligated RNA is insuffi-
cient on a preparative scale. For RNAs other
than P4-P6, the details of the electrophoresis
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must be determined empirically to identify ad-
equate separation conditions.
After preparing a sample by ligation ac-
cording to Basic Protocol 2 and before fluores-
cence spectroscopy, one can consider whether
a renaturation (annealing) step is necessary
(see UNIT 11.8). At this point, the annealing
procedure of Basic Protocol 3 may be per-
formed if desired. For P4-P6, the authors have
performed fluorescence experiments both with
and without a renaturation step. In equilibrium
fluorescence experiments the authors have ob-
served indistinguishable results, and typically
do not renature the sample for this purpose.
However, for stopped-flow fluorescence ex-
periments, modest differences in kinetics have
been observed, so it would be reasonable to
renature the sample before performing the ex-
periments. In general, the need for renaturation
after ligation should be checked experimen-
tally, and the renaturation may be omitted if it
is shown to be unnecessary.
RNA annealing
The Tris-borate buffer reported for anneal-
ing in Basic Protocol 3 (1× TB) is the same as
that typically used for nondenaturing gel elec-
trophoresis of structured RNAs (Silverman
and Cech, 1999a). This buffer has also proven
to be suitable for pyrene fluorescence spec-
troscopy, although various buffer identities and
strengths are acceptable (Silverman and Cech,
1999b). For other large RNAs, the effects
of buffer composition on fluorescence spec-
troscopy should be tested explicitly, as buffer-
dependent differences in folding rates have
been observed (Silverman et al., 2000).
In the annealing procedure, the heating tem-
perature should be high enough to denature
any undesired RNA secondary structures that
might be present, but it should not be so high
that nonspecificRNAdegradation is promoted.
The annealing buffer does not contain EDTA
to chelate any stray divalent metal ions that
may be present, because EDTA may interfere
with Mg2+ titrations during subsequent flu-
orescence experiments. Therefore, the com-
monly used annealing temperature of 90◦ to
95◦C (in the presence of EDTA; e.g., Basic
Protocol 2, step 3) is unwise in this context be-
cause any trace amount of a divalent ion such as
Ca2+ could lead to degradation during the heat-
ing step. The temperature of 60◦C reported in
Basic Protocol 3 is a compromise between the
need to denature and the need to avoid degra-
dation. For other large RNAs, the heating tem-
perature required for reproducible results must
be determined empirically.
Choice of site to derivatize the RNA with
pyrene
The choice of a specific nucleotide to be la-
beled with pyrene according to Figure 11.11.1
may be guided by available X-ray crystallog-
raphy or NMR spectroscopy data. For exam-
ple, the X-ray crystal structure of P4-P6 (Cate
et al., 1996) allowed sites for 2′-derivatization
to be chosen in a rational manner (Silverman
and Cech, 1999b; M.K. Smalley and S.K. Sil-
verman, unpub. observ.). These results have
led to the general prediction that many sites
within other large RNAs should be good can-
didates for modification, even without guid-
ance from high-resolution structural informa-
tion. If the large RNA of interest has no high-
resolution structure available, then a reason-
able strategy is to choose multiple sites and
prepare several pyrene-labeled versions of the
RNA in parallel. An appropriate structural or
functional assay (e.g., nondenaturing gel elec-
trophoresis or catalytic activity) should then be
performed to determine if the pyrene derivati-
zations have disrupted the RNA structure sig-
nificantly. Only those pyrene-labeled RNAs
that function well in the appropriate assay
should be pursued further using fluorescence
experiments.
Choice of site(s) to divide the RNA for
assembly
Each of the two strategies of Figure 11.11.2
requires choosing at least one site at which to
divide theRNA. If the derivatization site is very
close to the ligation junction (Fig. 11.11.2B),
then T4 DNA ligase–mediated joining of the
two RNA fragments may not work well. This
problem is observed when a pyr3 modification
is included merely three nucleotides from the
ligation site within P4-P6 (M.K. Smalley and
S.K. Silverman, unpub. observ.). Because the
success of splint ligation is difficult to predict
as described above, it is best to avoid designing
a ligation site very close to the derivatization
site. Regardless of the location of the ligation
site, the ligation efficiency should be checked
on the analytical scale using 32P-radiolabeled
RNAsbefore committing large amounts ofma-
terial to preparative reactions. Alternatively, if
the annealing strategy of Figure 11.11.2C can
be used instead of ligation, then this obviates
the issue of derivatization interfering with lig-
ation.
Anticipated Results
Once tractable derivatization and liga-
tion or annealing conditions are established,
synthesis of pyrene-labeled RNA is usually
RNA Folding
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uneventful. Starting from10 nmol of unlabeled
2′-amino oligonucleotide and assuming aver-
age yields of derivatization and ligation, ∼1 to
2 nmol of pyrene-labeled RNA is expected. At
a concentration of 300 nM, which is typical for
equilibrium fluorescence studies, this is suf-
ficient for three to six experiments. Stopped-
flow experiments require more material, and
the preparative reactionsmay need to be scaled
up several-fold. Typical results fromboth equi-
librium and stopped-flow fluorescence experi-
ments using pyrene-labeled P4-P6 are found in
the published papers of the authors (Silverman
andCech, 1999b, 2001; Silverman et al., 2000;
Young and Silverman, 2002).
Time Considerations
Once the appropriate 2′-amino RNA
oligonucleotide(s) and pyr3-STP are in hand,
testing the derivatization reaction typically
takes several days. Testing the ligation reac-
tions should require a similar length of time,
although several testing rounds may be needed
to find suitable sites. Finally, assaying the
derivatized and ligated RNA in structural or
functional assays may take several additional
weeks. Once appropriate derivatization and (if
necessary) ligation sites have been identified,
then equilibrium or stopped-flow fluorescence
experiments may be initiated. These are antic-
ipated to take several weeks at minimum.
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Key Reference
Silverman and Cech, 1999b. See above.
Presents the derivatization and ligation approaches
to synthesizing pyrene-labeled P4-P6 RNA.
Contributed by Mary K. Smalley and
Scott K. Silverman
University of Illinois at
Urbana-Champaign
Urbana, Illinois
